The Oncomine Dx Target Test may report erroneous results when used off-label for samples other than non-small cell lung cancer (NSCLC) tumor specimens.
Source facts
Action
The following actions are described in the consignee later: Review your testing results from the Oncomine Dx Target Test to ensure that none of the reports containing BRAF V600E positive samples are impacted. Utilize Figure 1 and 2 to aid in identifying this discrepancy. If you have any questions, please contact 408.802.2341.
Initiated
2017-12-04
Root cause
Device Design
Terminated
2020-11-10
Distribution
US Distribution to the states of: AZ, CA, NC, TX, and VA.
Recall number
Z-1279-2018
Recall status
Terminated
CDRH record ID
162327
FDA record created
2018-03-30
Recall event number
79437
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.